<DOC>
	<DOC>NCT02509871</DOC>
	<brief_summary>This cross-sectional study of pathophysiology will bring additional informations on body composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a complementary study of Metaca study (AU882).</brief_summary>
	<brief_title>Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>postmenopausal women patients requiring hormonal treatment WHO performance status 02 patients initially included in MetaCa (AU882) protocol Affiliation to a social security scheme (or be the beneficiary of such a plan) patients who signed the informed consent form patients witg relapse, with metastases or other cancer concurrent treatment with a drug test, or participation in a clinical trial within &lt; 30 days patients carrying an electronic medical device (eg pacemaker) patients who refused to sign the consent form</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Body composition</keyword>
</DOC>